Letter | Published:

Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid

Nature volume 509, pages 503506 (22 May 2014) | Download Citation



Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is essential for normal brain growth and cognitive function1,2,3,4. Consistent with its importance in the brain, DHA is highly enriched in brain phospholipids5,6,7. Despite being an abundant fatty acid in brain phospholipids, DHA cannot be de novo synthesized in brain and must be imported across the blood–brain barrier, but mechanisms for DHA uptake in brain have remained enigmatic. Here we identify a member of the major facilitator superfamily—Mfsd2a (previously an orphan transporter)—as the major transporter for DHA uptake into brain. Mfsd2a is found to be expressed exclusively in endothelium of the blood–brain barrier of micro-vessels. Lipidomic analysis indicates that Mfsd2a-deficient (Mfsd2a-knockout) mice show markedly reduced levels of DHA in brain accompanied by neuronal cell loss in hippocampus and cerebellum, as well as cognitive deficits and severe anxiety, and microcephaly. Unexpectedly, cell-based studies indicate that Mfsd2a transports DHA in the form of lysophosphatidylcholine (LPC), but not unesterified fatty acid, in a sodium-dependent manner. Notably, Mfsd2a transports common plasma LPCs carrying long-chain fatty acids such LPC oleate and LPC palmitate, but not LPCs with less than a 14-carbon acyl chain. Moreover, we determine that the phosphor-zwitterionic headgroup of LPC is critical for transport. Importantly, Mfsd2a-knockout mice have markedly reduced uptake of labelled LPC DHA, and other LPCs, from plasma into brain, demonstrating that Mfsd2a is required for brain uptake of DHA. Our findings reveal an unexpected essential physiological role of plasma-derived LPCs in brain growth and function.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern. Med. Rev. 12, 207–227 (2007)

  2. 2.

    & Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211–225 (1999)

  3. 3.

    & Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J. Am. Coll. Cardiol. 58, 2047–2067 (2011)

  4. 4.

    Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–175S (2000)

  5. 5.

    , & The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim. Biophys. Acta 266, 695–707 (1972)

  6. 6.

    Dietary (n-3) fatty acids and brain development. J. Nutr. 137, 855–859 (2007)

  7. 7.

    , , & Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36, 945–959 (2001)

  8. 8.

    et al. Pericytes regulate the blood–brain barrier. Nature 468, 557–561 (2010)

  9. 9.

    et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409–427 (2010)

  10. 10.

    , & Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism. PLoS ONE 7, e50629 (2012)

  11. 11.

    et al. Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nature Neurosci. 14, 345–350 (2011)

  12. 12.

    , , , & Phospholipid supplementation reverses behavioral and biochemical alterations induced by n-3 polyunsaturated fatty acid deficiency in mice. J. Lipid Res. 41, 473–480 (2000)

  13. 13.

    Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 282, 18661–18665 (2007)

  14. 14.

    The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233, 674–688 (2008)

  15. 15.

    , , & Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem. J. 345, 61–67 (2000)

  16. 16.

    , , , & Structural insights into the activation mechanism of melibiose permease by sodium binding. Proc. Natl Acad. Sci. USA 107, 22078–22083 (2010)

  17. 17.

    et al. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS). Proc. Natl Acad. Sci. USA 108, 17933–17938 (2011)

  18. 18.

    et al. Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys? PLoS ONE 6, e19731 (2011)

  19. 19.

    et al. Pregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice. PLoS ONE 7, e51455 (2012)

Download references


This work was supported in part by grants from the Singapore Ministry of Health’s National Medical Research Council CBRG/0012/2012 (to D.L.S.), the Singapore National Research Foundation Competitive Research Program grants 2008-01 (to E.L.G.) and 2007-04 (to M.R.W.), National University of Singapore’s Life Sciences Institute (to M.R.W.), and Singapore National Medical Research Council Translational and Clinical Research Program NMRC/TCR/003-GMS/2008 (to X.Z.). We would like to thank B. Tan (Duke-NUS) for technical assistance with lipid extractions, and S. Ying (Duke-NUS) for assistance with behavioural phenotyping.

Author information


  1. Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, 169857 Singapore

    • Long N. Nguyen
    •  & David L. Silver
  2. Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School Singapore, 8 College Road, 169857 Singapore

    • Dongliang Ma
    • , Peiyan Wong
    • , Xiaodong Zhang
    •  & Eyleen L. K. Goh
  3. Department of Biochemistry, National University of Singapore, 8 Medical Drive, Block MD7, 117597 Singapore

    • Guanghou Shui
    • , Amaury Cazenave-Gassiot
    •  & Markus R. Wenk


  1. Search for Long N. Nguyen in:

  2. Search for Dongliang Ma in:

  3. Search for Guanghou Shui in:

  4. Search for Peiyan Wong in:

  5. Search for Amaury Cazenave-Gassiot in:

  6. Search for Xiaodong Zhang in:

  7. Search for Markus R. Wenk in:

  8. Search for Eyleen L. K. Goh in:

  9. Search for David L. Silver in:


L.N.N. designed experiments; performed all in vitro experiments, in vitro and in vivo transport experiments in cells and mice, lipid extractions for lipidomic analysis, and fluorescence microscopy; analysed all data; and wrote the paper. D.M. performed immunolocalization studies and provided some technical support with mouse perfusions. G.S. performed lipidomic analysis. P.W. performed behaviour and learning and memory studies in mice. A.C.-G. performed lipidomic analysis. X.Z. supervised the behavioural core. M.R.W. supervised the lipidomic analysis. E.L.K.G. provided expertise with designing and interpreting immunolocalization studies. D.L.S. conceived and designed the study and experiments, performed in vivo transport experiments, analysed data, and wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to David L. Silver.

Extended data

Supplementary information

PDF files

  1. 1.

    Supplementary Information

    This file contains a Supplementary Discussion and additional references.

Excel files

  1. 1.

    Supplementary Table 1

    Mass spectrometry analysis of free fatty acid uptake in HEK239 cells. Mfsd2a expressing HEK293 cells were incubated with 100µM of indicated fatty acid/BSA complex overnight. Lipids extraction and phospholipid analysis by MS were performed as described in Methods section. Amount of each lipid species was normalized to internal standard and expressed as mol percent in total phospholipid analysed.

About this article

Publication history






Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.